Atreca's Unattributed Round

Atreca raised a round of funding on February 29, 2012.

Atreca is a privately held biotechnology company developing novel therapeutics drawn from human immune responses, including effective anti-cancer immune responses. The company is able to measure and a…

Articles about Atreca's Unattributed Round: